Biosimilar Monoclonal Antibodies in Oncology Will Approach Blockbuster Status by 2017
Opportunity for Biosimilars Varies Significantly by Therapeutic Area, According to a New Report from Decision Resources WALTHAM, Mass., Oct. 14 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds ...Epitomics receives ISO 9001 certification for the production of Rabbit Monoclonal Antibodies.
BURLINGAME, Calif., May 6 /PRNewswire/ -- Epitomics, Inc. announced today that its Hangzhou subsidiary has received ISO 9001-2000 certification for the development and production of its novel line of rabbit monoclonal antibodies. "This certification demonstrates our commitment to establishing ...A New Monoclonal Antibody Kills Cancer Cells
Researchers from the University of Pittsburgh School of Medicine report a significant new advance in the search for an effective treatment for human liver cancer in the July issue of Molecular Cancer Therapeutics. Using a newly available monoclonal antibody, they demonstrated significant redu...Survival of Mice With Human Breast Cancer Extended by Monoclonal Antibodies
According to a study done by Kate Rittenhouse-Olson, Ph.D., the monoclonal antibody developed by researchers at the University at Buffalo has been shown to extend// significantly the survival of mice with human breast-cancer tumors. The study also finds that the antibody inhibits the cancer's s...Therapeutic Monoclonal Antibody Production Is More Profitable Than Small Molecule Drugs
New study has suggested that therapeutics based on monoclonal antibodies (mAbs) are fare more likely to be commercially successful than their small molecule predecessors. According to a study completed by // consultancy Propagate Pharma, about half the mAbs launched so fare appear to be profitable....Micromet, Inc. Reports Second Quarter 2009 Financial Results
...eveloped from the currently marketed EGFR-specific monoclonal antibodies Erbitux(R) (cetuximab) and Vectibix(R) ...ome the resistance of mutated tumor cells to those monoclonal antibodies. Micromet also presented data at the AA... 2009 on a phase 1b combination study of its human monoclonal antibody adecatumumab with docetaxel in patients w...DSM Announces SafeBridge(R) Potent Compound Safety Certification
...opment, registered intermediates, registered starting materials, active pharmaceutical ingredients (API's), fermentation, mammalian cell production of monoclonal antibodies and proteins, formulation development, clinical trial manufacturing and finished dose form manufacturing of solids, semi-solids, and schedu...PDL BioPharma Elects Barry Selick to Its Board of Directors
...ociety Senior Fellow at the University of California, San Francisco. About PDL BioPharma, Inc. PDL BioPharma pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on m...PDL BioPharma Announces Second Quarter 2009 Financial Results
...o the call to allow for any software download that may be necessary. About PDL BioPharma, Inc. PDL BioPharma pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on m...JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in lab
... A novel anticancer agent, consisting of a monoclonal antibody linked to a chemotherapy drug, showed substantial antitumor activity in ovarian cancer cell lines and in mice, according to a study published...Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
...nd oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog which has ...Eleven Veterinary Students Win Top Awards at Morris Animal Foundation's Annual Research Competition
...uth African National Parks 3rd Place for Wildlife, $1,500 Santiago Diaz, University of Florida D07ZO-607 : "Use of Elephant-Specific monoclonal Antibodies and Recombinant Antigens of Mycobacterium tuberculosis to Improve an ELISA Test for Elephants" IMPACT Award, $500 Ana Iris Mot...Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
...nd oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog which has ...UPDATE: Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
...nd oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demo...Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
...nd oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demo...Access Pharmaceuticals to Present at Jessup & Lamont 2009 Growth Stock Conference
...nd oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demo...Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
...final ruling. The company began enrolling patients in two separate but identical Phase III clinical trials of solanezumab, an anti-amyloid beta monoclonal antibody being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer's disease. The trials each include a treat...New Alzheimer's Treatment Could Be on the Horizon
...ving the immune system a boost and slowing down, or preventing, the buildup of the toxic plaque. Several drug companies are also at work developing monoclonal antibodies, or artificially produced drugs, to prevent the beta-amyloid buildup. Despite the study's promising results, the researchers said, they'...Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab)
...included anaphylactic reactions, bronchospasm, and hypotension. Although not reported with Vectibix, fatal infusion reactions have occurred with other monoclonal antibody products. Stop infusion if a severe infusion reaction occurs. Depending on the severity and/or persistence of the reaction, permanently disco...QuikByte Software, Inc. and Sorrento Therapeutics, Inc. Announce Merger Agreement
...tform technology for the generation of fully human monoclonal antibodies, and QuikByte Software, Inc. (OTC Bulle...etary technology for the generation of fully human monoclonal antibodies." Glenn L. Halpryn stated "We ...licable platform for the generation of fully human monoclonal antibodies based on its proprietary technology. So...Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
... 431883#. About Peregrine Pharmaceuticals Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing three separate clinical programs in ca...Fluorescent probes may permit monitoring of chemotherapy effectiveness, Stanford study shows
...rmed by chemical methods that the fluorescent probes were indeed binding to caspases. Next, the team performed experiments with a new, experimental monoclonal antibody that activates caspases, by a mechanism different from that of dexamethasone, and initiates apoptosis particularly in rapidly dividing cells ...New Report Just Published: World Multiple Myeloma Therapeutics Market Report
... Targeted Therapy II-34 Gene Therapy II-34 Immunotherapy II-34 monoclonal Antibody Treatment II-35 Vaccines II-35 Donor Lymphocyte Infusion I...er Plans Acquisition of ViaCell II-51 Favrille Announces Acquisition of monoclonal Antibody Range from Diversa II-52 Johnson & Johnson Secures Con...Toronto researcher's discovery points to a new treatment avenue for acute myeloid leukemia
...able progress in the understanding of what initiates and sustains cancer. Together with his collaborators Dr. Dick has developed the first anti-cancer monoclonal antibody therapy that specifically targets cancer stem cells. This discovery offers hope for the development of treatments that target the cancer stem...Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
...nd follow-up are continuing. Bavituximab is a monoclonal antibody with a unique mechanism that enables the ...rget for anti-cancer treatments. Bavituximab is a monoclonal antibody that binds specifically to these phosphol...rmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of...MedImmune Expands Access for Eligible Premature Infants to Receive Synagis(R) at No Cost
...ederal Poverty Level (FPL) guidelines established by the U.S. Department of Health and Human Services (HHS). Synagis is a biologic medicine known as a monoclonal antibody administered monthly to high-risk infants to prevent serious lower respiratory tract infection caused by respiratory syncytial virus (RSV), a...Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Greece by SpePharm
...nd oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog which has ...Phase 1 Study Initiated with Micromet Anti-GM-CS Human Antibody MT203
...BiTE(R) antibody platform, as well as conventional monoclonal antibodies. BiTE antibodies represent a new class ...erexpressed in many solid tumors. Micromet's human monoclonal antibody adecatumumab (MT201) also binds to EpCAM ...patients with metastatic breast cancer. Micromet's monoclonal antibody MT293, also known as TRC093, is licensed ...Elusys Therapeutics and Lonza Enter Into Manufacturing Agreement
...nt for the production of Anthim(TM), a therapeutic monoclonal antibody in late stage development for the treatme...derable experience in large-scale manufacturing of monoclonal antibodies and a well-established reputation with ...thim is a high-affinity, humanized and deimmunized monoclonal antibody that targets the protective antigen of B...